Opticon's lead devices are the OPTION-vf^®, OPTION-vm^TM, and OPTION-v^TM CDA which have received FDA clearance.

These products provide substantial benefits to patients, physicians and health care providers as they:

• Eliminate the tubes and collection bags that are required with Foley catheter systems
• Provide clinically proven, convenient and effective urinary management
• Mimic normal bladder functioning
• Provide greatly enhanced comfort and mobility
• Are less disruptive to normal daily activities
• Cause less self-consciousness and sleep disruption
• Are simple to use
• Have a combination of attributes that result in superior "quality of life" for patients